title: Differential gene expression of adrenomedullin receptors in pressure- and volume-overloaded heart--role of angiotensin II.
abstract: Left ventricular (LV) adrenomedullin (AM) gene expression differs between pressure overload (POL) and volume overload (VOL) and angiotensin II could be a critical stimulator of AM gene expression in POL and VOL models. Calcitonin receptor-like receptor (CRLR) co-expressed with receptor activity modifying protein 2 (RAMP2) or RAMP3 functions as an AM receptor. Levels of CRLR, RAMP2 and RAMP3 mRNA that were significantly increased within 24 h returned to the basal level at 5 days after the imposition of POL in the present study. In contrast, mRNA levels of CRLR and RAMP2 gradually increased over 6 weeks after the imposition of VOL. Continuous infusion of angiotensin II stimulated LV AM gene and AM receptor gene expression independently of LV peak-systolic and LV end-diastolic pressure. The gene expression of LV AM receptors increased in different types of cardiac overload. The present study revealed an intimate association between the AM signaling system and angiotensin II.
authors.affiliation: First Department of Internal Medicine, Miyazaki Medical College, 5200 Kihara, Kiyotake, 889-1692, Japan.
authors.forename: Hisamitsu
authors.initials: H
authors.lastname: Onitsuka
authors.forename: Takuroh
authors.initials: T
authors.lastname: Imamura
authors.forename: Kaoru
authors.initials: K
authors.lastname: Ito
authors.forename: Kenji
authors.initials: K
authors.lastname: Kuwasako
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Yamakawa
authors.forename: Shuji
authors.initials: S
authors.lastname: Hirano
authors.forename: Kazuo
authors.initials: K
authors.lastname: Kitamura
authors.forename: Tanenao
authors.initials: T
authors.lastname: Eto
mesh_terms: D000804:Angiotensin II / Q000378:metabolism*; D000818:Animals; D058286:Calcitonin Receptor-Like Protein; D004195:Disease Models, Animal; D005786:Gene Expression Regulation; D006321:Heart / Q000503:physiopathology*; D006439:Hemodynamics; D047908:Intracellular Signaling Peptides and Proteins; D008297:Male; D008565:Membrane Proteins / Q000235:genetics; D009687:Nuclear Proteins / Q000235:genetics; D011312:Pressure; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D058263:Receptor Activity-Modifying Protein 2; D058264:Receptor Activity-Modifying Protein 3; D058261:Receptor Activity-Modifying Proteins; D058265:Receptors, Adrenomedullin; D018003:Receptors, Calcitonin / Q000235:genetics; D018000:Receptors, Peptide / Q000235:genetics / Q000378:metabolism*; D044767:Ubiquitin-Protein Ligases
chemical_list: C545578:CALCRL protein, human; D058286:Calcitonin Receptor-Like Protein; C429530:DTL protein, human; D047908:Intracellular Signaling Peptides and Proteins; D008565:Membrane Proteins; D009687:Nuclear Proteins; C545503:RAMP2 protein, human; C545504:RAMP3 protein, human; D012333:RNA, Messenger; D058263:Receptor Activity-Modifying Protein 2; D058264:Receptor Activity-Modifying Protein 3; D058261:Receptor Activity-Modifying Proteins; D058265:Receptors, Adrenomedullin; D018003:Receptors, Calcitonin; D018000:Receptors, Peptide; D000804:Angiotensin II; D044767:Ubiquitin-Protein Ligases